WOODCLIFF LAKE, N.J., March 11, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 21, 2013, at 10:00 A.M. EDT to review its results of operations for the year ended December 31, 2012. Par is privately held and does not generally make its financial information available to the public. However, holders of Par's debt securities, certain prospective holders of Par's debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call and request access to the secured area of its website, in which Par provides access to its financial reports and certain other information relating to its business. Par currently anticipates making its year-end reporting package available on Par's secured website at the close of business on Tuesday, March 19, 2013. Detailed information concerning access to the conference call and to Par's reporting package is posted on Par's secured website at www.parpharm.com/financial information.
About Par Pharmaceutical Companies
Par Pharmaceutical Companies, Inc. is a privately-held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies, Inc.